← Eichor
Study identifier: NCT04525989 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Preoperative Short-Course Radiation Therapy With PROtons Compared to Photons In High-Risk RECTal Cancer (PRORECT)

Condition: Rectal Cancer  ·  Sponsor: Alexander Valdman

PhaseNA
Planned participants254
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

To investigate a potential toxicity benefit of preoperative radiation therapy with protons compared to conventional photon beam radiation therapy in patients with locally advanced rectal cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Alexander Valdman, MD, PhD  ·  +46(0)700021317  ·  alexander.valdman@regionstockholm.se

Always discuss trial participation with your own doctor first.

Locations (9)

Karolinska University Hospital, Theme Cancer, Dept of Pelvic cancerStockholm, Solna, SwedenRecruiting
Gävle HospitalGävle, SwedenRecruiting
Sahlgrenska University HospitalGothenburg, SwedenRecruiting
Linköping University HospitalLinköping, SwedenRecruiting
Skåne University HospitalLund, SwedenRecruiting
Stockholm South General HospitalStockholm, SwedenRecruiting
Sundsvall HospitalSundsvall, SwedenRecruiting
University Hospital of UmeåUmeå, SwedenRecruiting
Uppsala University HospitalUppsala, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04525989